ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
David A. Edwards, Gordon McKay Professor of the Practice of Biomedical Engineering at Harvard University is the winner of the Melvin Calvin Medal of Distinction, the highest honor given by Michigan Technological University.
The medal recognizes individuals who have had an affiliation with the university and who have exhibited distinguished professional and personal accomplishments. It is named for its first recipient, Michigan Tech alumnus Melvin E. Calvin, who won the 1961 Nobel Prize in Chemistry.
In his current research, Edwards is investigating fluid mechanical properties of the lung lining fluid that permit control of expired bioaerosol and the mitigation of spread of inhaled infectious disease agents. He is also developing novel antibiotic therapies for tuberculosis and a new delivery platform for childhood vaccines that can be delivered without a needle. He pioneered the technology of aerosol medication, including inhaled insulin.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X